MACUGEN (nda021756)- (EQ 0.3MG ACID/0.09ML)

Generic Name	PEGAPTANIB SODIUM	Innovator	BAUSCH AND LOMB INC
Dosage	EQ 0.3MG ACID/0.09ML
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2017-Jan-04	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	Macugen is indicated for the treatment of neovascular (wet) age-related macular degeneration.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 0.3MG ACID/0.09ML	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of MACUGEN